Paricalcitol and Extended Release Calcifediol for Treatment of Secondary Hyperparathyroidism in Non-Dialysis Chronic Kidney Disease: Results From a Network Meta-Analysis.

Matteo Franchi,Joel Gunnarsson,Emilio Gonzales-Parra,Anibal Ferreira,Oskar Ström,Giovanni Corrao

The Journal of clinical endocrinology and metabolism（2023）

引用 0|浏览3

暂无评分

摘要

This NMA showed that ERC is comparable in lowering PTH levels vs PCT. ERC displayed avoidance of potentially clinically relevant increases in serum calcium, offering an effective and well tolerated treatment option for the management of SHPT in patients with ND CKD.

查看译文

关键词

bone, mineral metabolism, hypercalcemia, hyperparathyroidism, metabolic bone disease, vitamin D

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要